Adaptive magnetic resonance-guided neurovascular-sparing radiotherapy for preservation of erectile function in prostate cancer patients
Author(s) -
Frederik R. Teunissen,
Ruud C. Wortel,
Jochem Hes,
T. Willigenburg,
Eline N. de Groot-van Breugel,
J C J de Boer,
Harm H.E. van Melick,
Helena M. Verkooijen,
Jochem R.N. van der Voort van Zyp
Publication year - 2021
Publication title -
physics and imaging in radiation oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.777
H-Index - 12
ISSN - 2405-6316
DOI - 10.1016/j.phro.2021.09.002
Subject(s) - neurovascular bundle , prostate cancer , medicine , erectile dysfunction , radiation therapy , prostate , urology , magnetic resonance imaging , radiology , cancer , surgery
Erectile dysfunction is a common adverse effect of external beam radiation therapy for localized prostate cancer (PCa), likely as a result of damage to neural and vascular tissue. Magnetic resonance-guided online adaptive radiotherapy (MRgRT) enables high-resolution MR imaging and paves the way for neurovascular-sparing approaches, potentially lowering erectile dysfunction after radiotherapy for PCa. The aim of this study was to assess the planning feasibility of neurovascular-sparing MRgRT for localized PCa.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom